Percutaneous preparations
View Patent ↗A bisphosphonic acid derivative-containing percutaneous preparation of an excellent percutaneous permeability, comprising a bisphosphonic acid derivative such as incadronic acid, minodronic acid, etc., or pharmaceutically acceptable salts thereof, a solubilizing agent for the derivative or pharmaceutically acceptable salts thereof, and an amphiphilic solubilizing auxiliary agent, which may optionally contain a suspension-type base such as a polyvalent alcohol, a higher fatty acid ester, a liquid hydrocarbon or a vegetable oil, etc. This preparation has an excellent percutaneous permeability, reduces burdens on the patient, does not deteriorate the patient's compliance even in the administration over a prolonged period of time and can achieve the therapeutic effects in a short period of time.
1. A plaster formulation comprising: (a) minodronic acid, or pharmaceutically acceptable salts thereof, at from 0.1 to 5 weight percent (b) 0.05 to 5 parts by weight of a solubilizing agent based on 1 part by weight of the minodronic acid or salt thereof, (c) N-methyl-2-pyrrolidone at from 3 to 8 weight percent, and (d) a styrene-isoprene-styrene block copolymer as an adhesive component.
2. The plaster formulation according to claim 1 , wherein the plaster formulation is in the form of a tape.
3. A method for treating diseases associated with accelerated bone resorption or ectopic calcification, comprising administering an effective amount of minodronic acid contained in the plaster formulation according to claim 1 to a patient in need thereof.